Grey Market Premium · Dec 08 – Dec 10, 2025 · Issue Price ₹1,062
Last updated:
The Corona Remedies IPO GMP is ₹342.50, last updated on 15 Dec 2025, 1:04 PM IST, indicating 32.3% expected listing gain, or about ₹4,795 per lot of 14 shares.
The Corona Remedies IPO Grey Market Premium (GMP) is currently trading at ₹342.50 in the unofficial grey market. Based on this, the expected listing price is ₹1,404.50, implying a +32.3% gain over the issue price of ₹1,062. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Last recorded GMP of each day (IST), newest first. Est. listing = upper price band + GMP.
| Date | GMP (₹) | Change | Est. Listing | Profit / Lot | Trend |
|---|---|---|---|---|---|
| 15 Dec 2025 1:04 pm | +₹342.50 (32.3%) | +₹51.50 | ₹1,404.50 | ₹4,795 | ▲ Up |
| 11 Dec 2025 2:35 pm | +₹291.00 (27.4%) | −₹4.00 | ₹1,353.00 | ₹4,074 | ▼ Down |
| 10 Dec 2025 6:02 pm | +₹295.00 (27.8%) | +₹25.00 | ₹1,357.00 | ₹4,130 | ▲ Up |
| 9 Dec 2025 4:15 pm | +₹270.00 (25.4%) | +₹8.00 | ₹1,332.00 | ₹3,780 | ▲ Up |
| 8 Dec 2025 4:00 pm | +₹262.00 (24.7%) | — | ₹1,324.00 | ₹3,668 | — |
Over the last 5 days with GMP data (8 Dec – 15 Dec 2025), the Corona Remedies IPO GMP moved from ₹262.00 to ₹342.50, a net change of +₹80.50 (+7.6% of the upper price band). It closed higher on 3, lower on 1 and unchanged on 0 of those days compared with the day before.
Plain calculations from our recorded entries. Rising = net change above +5% of the upper price band, falling = below −5%, stable = in between.
Grey market premium over time (₹)
5 entries recorded, newest first. Trend compares each entry with the one before it.
| # | Date / Time | GMP (₹) | Exp. Listing | Exp. Gain | Trend |
|---|---|---|---|---|---|
| 1 | Dec 15, 2025 1:04 pm | +₹342.50 | ₹1,404.50 | +32.3% | ▲ Up |
| 2 | Dec 11, 2025 2:35 pm | +₹291.00 | ₹1,353.00 | +27.4% | ▼ Down |
| 3 | Dec 10, 2025 6:02 pm | +₹295.00 | ₹1,357.00 | +27.8% | ▲ Up |
| 4 | Dec 09, 2025 4:15 pm | +₹270.00 | ₹1,332.00 | +25.4% | ▲ Up |
| 5 | Dec 08, 2025 4:00 pm | +₹262.00 | ₹1,324.00 | +24.7% | — |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The latest Corona Remedies IPO GMP is ₹342.50, recorded on 15 Dec 2025, 1:04 PM IST. At the ₹1,062 upper price band, this points to an estimated listing price of ₹1,404.50 (+32.3%).
Over the last 5 days with GMP data (8 Dec – 15 Dec 2025), the GMP moved from ₹262.00 to ₹342.50, a net change of +₹80.50 (+7.6% of the upper price band). That is a Rising trend by our definition: above +5% of the upper price band is rising, below −5% is falling, anything in between is stable.
The current GMP of ₹342.50 is +32.3% of the ₹1,062 upper price band (GMP ÷ upper price band × 100).
On 15 Dec 2025, the GMP closed at ₹342.50, up ₹51.50 from ₹291.00 on 11 Dec 2025.
The highest GMP we have recorded for Corona Remedies IPO is ₹342.50, on 15 Dec 2025, 1:04 PM IST.
Over the last 5 days with GMP data, the Corona Remedies IPO GMP ranged from ₹262.00 to ₹342.50.
At the current GMP of ₹342.50 and a lot size of 14 shares, the estimated profit is ₹4,795.00 per lot (GMP × lot size), before charges and taxes. It is indicative only.
Our team updates the Corona Remedies IPO GMP manually through the day while the IPO is active. We have recorded 5 entries since 8 Dec 2025; the latest was on 15 Dec 2025, 1:04 PM IST.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Corona Remedies IPO is expected to list on December 15, 2025 on NSE & BSE.
Not reliably. GMP shows what grey market participants were willing to pay at a point in time; the listing price is set by demand on the exchange on listing day and can differ widely from the last GMP.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.